Ocular Therapeutix Inc (OCUL) stock news · rev $52.0M
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
This OCUL news page leads with what Ocular Therapeutix Inc filed — not a scraped headline mill.
No cached 8-K sentence for OCUL yet. We will not pad this page with generic market recap.
Latest reported OCUL revenue for 2025-12-31 was $52.0M. Net income was -$265.9M. Revenue was down 18.5% from 2024-12-31 to 2025-12-31. OCUL currently screens at market cap $1.76B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OCUL stock page; for the tape open the quote page.
OCUL stock news FAQ
What are OCUL's latest revenue and net income?
Latest cached Ocular Therapeutix Inc (OCUL) revenue for Dec 31, 2025 was $52.0M. Net income was -$265.9M. Statements: https://lician.com/financials/ocul
How did OCUL revenue change from the prior cached period?
Cached Ocular Therapeutix Inc (OCUL) revenue was down 18.5% from $63.7M (Dec 31, 2024) to $52.0M (Dec 31, 2025). Statements: https://lician.com/financials/ocul
What is OCUL's market cap?
Ocular Therapeutix Inc (OCUL) market cap is $1.76B on the latest cached fundamentals snapshot.
What kind of company is OCUL?
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Where is OCUL stock news listed?
Cached stock news for Ocular Therapeutix Inc (OCUL) is listed at https://lician.com/news/ocul. Filings: https://lician.com/sec/ocul
Not investment advice.